<DOC>
	<DOC>NCT03074903</DOC>
	<brief_summary>Women presenting for contraception will be offered the IUS Skyla and study participation. Daily bleeding will be collected for a total of 90 days and correlated with insertion timing and baseline endometrial thickness.</brief_summary>
	<brief_title>Does Skyla Insertion Timing Impact Bleeding?</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<criteria>Women aged 1845 Parous or nulliparous Desire Skyla for contraception Regular menstrual cycles (2135 days) Working mobile phone and willing to accept text messages and report daily bleeding data for 90 days Vaginal or cesarean delivery in the past 12 weeks Abortion in the past 6 weeks Uterine anomaly distorting the uterus Acute pelvic inflammatory disease Uterine bleeding of unknown etiology Acute liver disease or tumor History of progestinsensitive cancer Abnormal pap smear awaiting diagnostic or therapeutic intervention</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>intrauterine device</keyword>
	<keyword>bleeding</keyword>
</DOC>